Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015;11(4):870-4.
doi: 10.1080/21645515.2015.1012028.

A universal infant rotavirus vaccine program in two delivery models: Effectiveness and adverse events following immunization

Carolyn Sanford  1 , Joanne M Langley, Scott A Halperin, Mitchell Zelman, Mvrvp
Affiliations

A universal infant rotavirus vaccine program in two delivery models: Effectiveness and adverse events following immunization

Carolyn Sanford et al. Hum Vaccin Immunother. 2015.

Abstract

Rotavirus is the most common cause of diarrhea leading to hospitalization in young children. Rotavirus vaccines are available in Canada but have not been introduced in all provinces. In a controlled trial, 2 study sites (Prince Edward Island and the Capital District Health Authority (District 9, Nova Scotia) introduced universal rotavirus vaccine programs for infants at 2 and 4 months of age beginning 1 December 2010, using public health nurse or general practitioner-delivery models, respectively. A third site (Saint John, NB) served as the non-intervention control setting. Vaccine coverage, rotavirus hospitalizations, intussusception and all-cause diarrhea were monitored. A universal rotavirus vaccine program with >90% coverage was associated with reductions in rotavirus-associated hospitalizations (from a peak of 52.8 hospitalizations/100,000 population to 0 hospitalizations) in infants < 12 months and 1 to < 2 y of age 12 months after program implementation. No apparent reduction occurred in the site with vaccine coverage of < 40%, or in the non-intervention control site. No cases of intussusception were associated with vaccine receipt, and no increase in all-cause diarrhea was observed. A universal infant rotavirus vaccine program with high coverage was associated with reductions in rotavirus and no safety signals; no reduction was observed in settings with low vaccine coverage.

Keywords: Clinical Trials registration; NCT01273077; Rotavirus vaccines; immunization programs; public health practice.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Rotavirus admissions in children < 12 months of age/1000 population/month January 2008—May 2013.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Tate JE, Patel MM, Steele AD, Gentsch JR, Payne DC, Cortese MM, Nakagomi O, Cunliffe NA, Jiang B, Neuzil KM, et al. . Global impact of rotavirus vaccines. Expert Rev Vaccines 2010; 9(4):395-407; PMID:20370550; http://dx.doi.org/10.1586/erv.10.17 - DOI - PubMed
    1. Strategic Advisory Group of Vaccine Experts World Health Organization. Meeting of the immunization Strategic Advisory Group of Experts, April 2009 – conclusions and recommendations. Wkly Epidemiol Rec. 2009;84(23):220-36. - PubMed
    1. National Advisory Committee on Immunization. Updated statement of the use of rotavirus vaccines. Can Commun Dis Rep. 2010;36(ACS-4):1-36. - PMC - PubMed
    1. Buigues RP, Duval B, Rochette L, Boulianne N, Douville-Fradet M, Dery P, De Serres G. Hospitalizations for diarrhea in Quebec children from 1985 to 1998: Estimates of rotavirus-associated diarrhea. Can J Infect Dis 2002; 13(4):239-44; PMID:18159396 - PMC - PubMed
    1. National Advisory Committee on Immunization. Statement on the recommended use of pentavalent human-bovine reassortant rotavirus vaccine. Can Commun Dis Rep. 2008;34(ACS-1):33. - PubMed

Publication types

Substances